https://wikimd.org/index.php?action=history&feed=atom&title=TPA-023TPA-023 - Revision history2026-04-27T06:59:10ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=TPA-023&diff=6304846&oldid=prevPrab: CSV import2025-02-17T01:46:03Z<p>CSV import</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:46, 17 February 2025</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l21">Line 21:</td>
<td colspan="2" class="diff-lineno">Line 21:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{stub}}</div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">== TPA-023 ==</ins></div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"><gallery></ins></div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:TPA-023.png</ins></div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:TPA-023_3D_ball.png</ins></div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></gallery></ins></div></td></tr>
</table>Prabhttps://wikimd.org/index.php?title=TPA-023&diff=5300773&oldid=prevPrab: CSV import2024-02-25T22:40:30Z<p>CSV import</p>
<p><b>New page</b></p><div>'''TPA-023''' is a drug that belongs to the [[benzodiazepine]] class of medications. It was developed by a pharmaceutical company called [[Takeda Pharmaceuticals]]. TPA-023 is primarily used in the treatment of [[anxiety]] and [[insomnia]]. It is a partial agonist at GABA<sub>A</sub> receptors, which means it can produce similar effects to those of other benzodiazepines, but with less risk of dependency and withdrawal symptoms.<br />
<br />
==Pharmacology==<br />
TPA-023 acts as a partial agonist at [[GABA<sub>A</sub> receptors]], which are a type of protein in the brain that responds to the neurotransmitter GABA, the main inhibitory neurotransmitter in the mammalian central nervous system. This action enhances the effect of GABA in the brain, leading to sedative and anxiolytic effects.<br />
<br />
==Clinical Use==<br />
TPA-023 has been studied for use in the treatment of [[Generalized Anxiety Disorder (GAD)]] and [[insomnia]]. In clinical trials, it has shown efficacy in reducing the symptoms of these conditions, with a lower risk of dependency and withdrawal symptoms compared to other benzodiazepines.<br />
<br />
==Development and Approval==<br />
TPA-023 was developed by [[Takeda Pharmaceuticals]], a Japanese multinational pharmaceutical company. However, development was discontinued in 2007 due to concerns about toxicity in animal studies.<br />
<br />
==See Also==<br />
* [[Benzodiazepine]]<br />
* [[GABA<sub>A</sub> receptor]]<br />
* [[Takeda Pharmaceuticals]]<br />
<br />
[[Category:Drugs]]<br />
[[Category:Benzodiazepines]]<br />
[[Category:Anxiolytics]]<br />
[[Category:Hypnotics]]<br />
<br />
{{stub}}</div>Prab